The disease burden of inflammatory bowel diseases (IBD) in India is estimated to be one of the highest in the world in the near future. Patients with IBD, particularly those on immunosuppressive therapy, are at increased risk for developing vaccine-preventable illnesses. Adult vaccination policy and vaccination in patients with IBD are presently being at a very low level in India. This review discusses in detail the need for vaccination, levels of immunosuppression, a brief account of live and inactivated vaccines, available vaccines, and their utility in patients with IBD, with a special focus on recent recommendations.
All Keywords
【저자키워드】 Immunosuppression, biosimilars, Crohn disease, Infection prevention, ulcerative colitis, Biologicals, vaccine types, vaccine recommendations,
【저자키워드】 Immunosuppression, biosimilars, Crohn disease, Infection prevention, ulcerative colitis, Biologicals, vaccine types, vaccine recommendations,